Brief: IX Biopharma Entered Into Agreement With China Resources Pharmaceutical Commercial Group
06/04/2021 13:07
April 6 (Reuters) - IX Biopharma Ltd IXBI.SI :
* ENTERED INTO A STRATEGIC COOPERATION FRAMEWORK AGREEMENT
WITH
CHINA RESOURCES PHARMACEUTICAL COMMERCIAL GROUP
* UNDER DEAL, PARTIES TO COOPERATE FOR IX BIOPHARMA'S
PIPELINE OF
SUBLINGUAL PHARMACEUTICAL & NUTRACEUTICAL PRODUCTS IN CHINA
Source text for Eikon: ID:nSNZ7CbZHv
Further company coverage: IXBI.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine
Brief: IX Biopharma To Raise At Least S$6 MLN Via Placement At S$0.198 Per Share
Brief: IX Biopharma Enters Term Sheet For Proposed Joint Venture